 |
|
KASL clinical practice guidelines for management of chronic hepatitis B
Clin Mol Hepatol. 2022;28(2):276-331. Published online 2022 Apr 1 DOI: https://doi.org/10.3350/cmh.2022.0084
|
|
Citations to this article as recorded by
 Gray zone of hepatitis B virus infection
Young-Suk Lim
Saudi Journal of Gastroenterology.2024; 30(2): 76. CrossRef PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
Ho Soo Chun, George V. Papatheodoridis, Minjong Lee, Hye Ah Lee, Yeong Hwa Kim, Seo Hyun Kim, Yun-Seo Oh, Su Jin Park, Jihye Kim, Han Ah Lee, Hwi Young Kim, Tae Hun Kim, Eileen L. Yoon, Dae Won Jun, Sang Hoon Ahn, Vana Sypsa, Cihan Yurdaydin, Pietro Lampe
Journal of Hepatology.2024; 80(1): 20. CrossRef Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment
Hyeyeon Hong, Minjoo Cho, Chaeyeon Lim, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Jonggi Choi
Alimentary Pharmacology & Therapeutics.2024; 59(4): 515. CrossRef Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
Liandong Wu, Zhenggang Yang, Min Zheng
Journal of Viral Hepatitis.2024; 31(5): 255. CrossRef Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
Diagnostics.2024; 14(5): 495. CrossRef Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
OncoTargets and Therapy.2024; Volume 17: 215. CrossRef Linvencovir: Paving the way for functional cure in hepatitis B
Jiwon Yang, Jonggi Choi
Clinical and Molecular Hepatology.2024; 30(2): 164. CrossRef Lack of Association between Early On-Treatment HBeAg-Seroclearance and Development of Hepatocellular Carcinoma or Decompensated Liver Cirrhosis
Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
JHEP Reports.2024; : 101089. CrossRef Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
Infectious Agents and Cancer.2023;[Epub] CrossRef Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee
European Journal of Gastroenterology & Hepatology.2023; 35(4): 431. CrossRef Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues
Tyng‐Yuan Jang
Alimentary Pharmacology & Therapeutics.2023; 57(5): 587. CrossRef The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(5): 716. CrossRef Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
Frontiers in Oncology.2023;[Epub] CrossRef 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Journal of Liver Cancer.2023; 23(1): 1. CrossRef Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study
Moon Haeng Hur, Min Kyung Park, Terry Cheuk-Fung Yip, Chien-Hung Chen, Hyung-Chul Lee, Won-Mook Choi, Seung Up Kim, Young-Suk Lim, Soo Young Park, Grace Lai-Hung Wong, Dong Hyun Sinn, Young-Joo Jin, Sung Eun Kim, Cheng-Yuan Peng, Hyun Phil Shin, Chi-Yi Ch
American Journal of Gastroenterology.2023; 118(11): 1963. CrossRef Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
Jeong-Ju Yoo, Sang Gyune Kim
Clinical and Molecular Hepatology.2023; 29(2): 513. CrossRef The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
Moon Haeng Hur, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2023; 29(2): 363. CrossRef Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clinical and Molecular Hepatology.2023; 29(2): 367. CrossRef Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
Eui Gwon Hwang, Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
Hepatology International.2023; 17(4): 860. CrossRef Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2023; 58(1): 99. CrossRef Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
Diagnostics.2023; 13(9): 1537. CrossRef CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B
Hye Yeon Chon, Han Ah Lee, Soo Young Park, Yeon Seok Seo, Sang Gyune Kim, Chang Hun Lee, Tae Hee Lee, Sang Hoon Ahn, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Lilian Yan Liang, In Hee Kim, Grace Lai‐Hung Wong, Seung Up Kim
Journal of Digestive Diseases.2023; 24(2): 113. CrossRef Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study
Jihye Kim, Moon Haeng Hur, Seung Up Kim, Jin-Wook Kim, Dong Hyun Sinn, Hyun Woong Lee, Moon Young Kim, Jae Youn Cheong, Yong Jin Jung, Han Ah Lee, Young-Joo Jin, Jun Sik Yoon, Sung-Jae Park, Chang Hun Lee, In Hee Kim, June Sung Lee, Young Youn Cho, Hyung
Cancers.2023; 15(11): 2936. CrossRef Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT
宇行 刘
Advances in Clinical Medicine.2023; 13(05): 8702. CrossRef Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
BMC Cancer.2023;[Epub] CrossRef Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
BMC Gastroenterology.2023;[Epub] CrossRef A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
Liver International.2023; 43(8): 1813. CrossRef Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non‐cirrhotic patients with chronic hepatitis B
Cheol‐Hyung Lee, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
Alimentary Pharmacology & Therapeutics.2023; 58(7): 704. CrossRef Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Young-Suk Lim
Gut.2023; : gutjnl-2023-330225. CrossRef The efficacy of treatment for hepatocellular carcinoma in elderly patients
Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
Journal of Liver Cancer.2023; 23(2): 362. CrossRef Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia
Grace Chung‐Yan Lui, Grace Lai‐Hung Wong, Hung‐Chih Yang, Wang‐Huei Sheng, Sun Hee Lee
HIV Medicine.2023; 24(10): 1035. CrossRef Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
BMC Gastroenterology.2023;[Epub] CrossRef Adult-onset hypophosphatemic osteomalacia as a cause of widespread musculoskeletal pain: A retrospective case series of single center experience
Sungwon Kim, Sun Woong Kim, Byung Chan Lee, Du Hwan Kim, Duk Hyun Sung
World Journal of Clinical Cases.2023; 11(32): 7785. CrossRef Hepatocellular carcinoma presenting as organized liver abscess: A case report
Sung Hyeok Ryou, Hyun Deok Shin, Suk Bae Kim
World Journal of Clinical Cases.2023; 11(33): 8078. CrossRef The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
Jung Kim, Sung-Eun Kim, Do Song, Hee Kim, Eileen Yoon, Seong Kang, Young-Kul Jung, Jung Kwon, Sung Lee, Seul Han, Young Chang, Soung Jeong, Jeong Yoo, Young-Joo Jin, Gab Cheon, Byung Kim, Yeon Seo, Hyoungsu Kim, Ji Park, Tae Kim, Dong Sinn, Woo Chung, Hwi
Diagnostics.2023; 14(1): 14. CrossRef Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
Clinical and Molecular Hepatology.2023; 30(1): 49. CrossRef Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
Medicine.2023; 102(43): e34276. CrossRef Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scientific Reports.2022;[Epub] CrossRef Reply to: “A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations”
Hyun Yang, Si Hyun Bae, Jeong Won Jang
Journal of Hepatology.2022; 77(6): 1724. CrossRef Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park
The Korean Journal of Gastroenterology.2022; 80(2): 51. CrossRef 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2022; 23(12): 1126. CrossRef Updated Treatment Guidelines for Chronic Hepatitis B
Jihyun An
The Korean Journal of Medicine.2022; 97(6): 353. CrossRef
|